Sound Bioventures
Overview
Sound Bioventures is a venture capital fund investing in about-to-be clinical and clinical stage private companies in Europe and the USA developing novel medicines that addresses unmet medical needs. The fund focuses on companies with assets in clinical or about-to-be-clinical stage in primarily orphan and rare diseases. It leverages Scandinavian science to build companies and facilitate cross-Atlantic exchange of innovation, sector knowledge and capital.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Artax Biopharma | Aug 2024 | Convertible Debt | Co-investor |
| Altay Therapeutics | Oct 2026 | Series A | Lead |
| AnaCardio | Sep 2026 | Series B | Co-investor |
| AbolerIS Pharma | Sep 2023 | Series A | Co-investor |
| Theolytics | Apr 2024 | VC Round | Lead |
For institutional investors. Book with your work email.
Key People
Ester Sklarsky
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sound Bioventures based?
Sound Bioventures is headquartered in Sweden.
When was Sound Bioventures founded?
Sound Bioventures was founded in 2021.
How many portfolio companies does Sound Bioventures have?
Sound Bioventures has 12 portfolio companies in Caplight's dataset.
What are some companies in Sound Bioventures's portfolio?
Portfolio companies visible on Caplight include Artax Biopharma, Altay Therapeutics, AnaCardio, AbolerIS Pharma, Theolytics.
What was Sound Bioventures's most recent investment shown here?
Sound Bioventures's most recent investment in this portfolio sample was in Altay Therapeutics in 2026.
What sectors does Sound Bioventures focus on?
Sound Bioventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Sound Bioventures focus on?
Sound Bioventures typically invests at the MultiStage stage.
What is Sound Bioventures's AUM?
Sound Bioventures's assets under management are estimated between $100.0M and $250.0M.